US Stock MarketDetailed Quotes

MYGN Myriad Genetics

Watchlist
  • 12.820
  • +0.060+0.47%
Close Jan 24 16:00 ET
  • 12.700
  • -0.120-0.94%
Post 17:52 ET
1.17BMarket Cap-10.02P/E (TTM)

Myriad Genetics Key Stats

Myriad Genetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 210.825M--
--2024/Q4-- / 212.529M--
Nov 7, 20242024/Q3213.300M / 210.794M--
Aug 6, 20242024/Q2211.500M / 205.006M--
May 7, 20242024/Q1202.200M / 193.251M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 210.825M--
--2024/Q4-- / 212.529M--
Nov 7, 20242024/Q3213.300M / 210.794M--
Aug 6, 20242024/Q2211.500M / 205.006M--
May 7, 20242024/Q1202.200M / 193.251M--

Unlock Free Earnings Estimates

Myriad Genetics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 22, 2025

Hold

  • Buy

    12.50%
  • Hold

    62.50%
  • Sell

    25.00%

Price Target

No Data